Globus Medical Schedules Fourth Quarter and Full Year 2021 Earnings Release and Conference Call

3 years ago

AUDUBON, Pa., Jan. 27, 2022 (GLOBE NEWSWIRE) -- Globus Medical, Inc. (NYSE:GMED), a leading musculoskeletal solutions company, will announce its…

CooperCompanies Announces Release Date for First Quarter 2022

3 years ago

SAN RAMON, Calif., Jan. 27, 2022 (GLOBE NEWSWIRE) -- CooperCompanies (NYSE: COO) today announced it will release first quarter 2022…

Vaccinex Announces $6.6 Million Private Placement

3 years ago

Participants include a syndicate of existing and new shareholdersContributes to total of $10.1 million in new equity financing for January,…

Stryker reports 2021 operating results and 2022 outlook

3 years ago

Kalamazoo, Michigan, Jan. 27, 2022 (GLOBE NEWSWIRE) -- Stryker (NYSE:SYK) reported operating results for the fourth quarter and full year…

23andMe to Report FY2022 Third Quarter Financial Results

3 years ago

SUNNYVALE, Calif., Jan. 27, 2022 (GLOBE NEWSWIRE) -- 23andMe Holding Co. (Nasdaq: ME) (“23andMe”), a leading consumer genetics and research…

ResMed Inc. Announces Results for the Second Quarter of Fiscal Year 2022

3 years ago

Year-over-year revenue grows 12%, operating profit up 12%, non-GAAP operating profit up 5%Note: A webcast of ResMed’s conference call will…

NeuroPace to Report Fourth Quarter and Full Year 2021 Financial Results and Present at the 11th Annual SVB Leerink Global Healthcare Conference 

3 years ago

MOUNTAIN VIEW, Calif., Jan. 27, 2022 (GLOBE NEWSWIRE) -- NeuroPace, Inc. (Nasdaq: NPCE), a commercial-stage medical device company focused on…

VitalHub Corp. Announces Acquisition of Beautiful Information

3 years ago

TORONTO, Jan. 27, 2022 (GLOBE NEWSWIRE) -- VITALHUB CORP. (TSX: VHI) (the “Company” or “VitalHub”) is pleased to announce today…

Freeline to Present on Its Fabry and Gaucher Disease AAV-Based Gene Therapies at the 18th Annual WORLDSymposium™

3 years ago

LONDON, Jan. 27, 2022 (GLOBE NEWSWIRE) -- Freeline Therapeutics Holdings plc (Nasdaq: FRLN) (the “Company” or “Freeline”), a clinical-stage biotechnology…

Nurix Therapeutics Reports Fourth Quarter and Fiscal Year 2021 Financial Results and Provides a Corporate Update

3 years ago

Advanced four wholly owned and internally developed programs into clinical development Strengthened balance sheet with year-end cash and investments totaling…